Equitable Trust’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,686
Closed -$3.01M 451
2025
Q3
$3.01M Sell
24,686
-1,208
-5% -$156K 0.14% 127
2025
Q2
$3.51M Sell
25,894
-432
-2% -$58.3K 0.18% 105
2025
Q1
$3.56M Sell
26,326
-1,629
-6% -$215K 0.2% 96
2024
Q4
$3.85M Buy
27,955
+1,115
+4% +$157K 0.21% 92
2024
Q3
$3.69M Sell
26,840
-1,306
-5% -$166K 0.24% 93
2024
Q2
$3.23M Buy
28,146
+4,674
+20% +$540K 0.22% 94
2024
Q1
$2.74M Buy
23,472
+637
+3% +$71.7K 0.19% 105
2023
Q4
$2.48M Buy
22,835
+2,219
+11% +$223K 0.19% 103
2023
Q3
$2.03M Hold
20,616
0.17% 112
2023
Q2
$2.18M Buy
+20,616
New +$2.19M 0.17% 109

Other funds holding INGR

Equitable Trust's INGR Position: Q4 2025 in Review

Equitable Trust sold out of Ingredion (INGR) in Q4 2025, closing a stake of 24,686 shares — an estimated $3.01M sold.

Equitable Trust first reported a position in INGR in Q2 2023 and held it in 10 quarters. The position peaked at $3.85M in Q4 2024. 650 funds tracked by Wall St. Rank hold INGR as of Q4 2025.

  • Equitable Trust reported no remaining Ingredion position as of Q4 2025 after selling out during the quarter.
  • Equitable Trust sold 24,686 Ingredion shares in Q4 2025, an estimated $3.01M.
  • Equitable Trust first reported a position in Ingredion in Q2 2023 and held it in 10 quarters.
  • Equitable Trust's Ingredion position peaked at $3.85M in Q4 2024.
  • 650 funds tracked by Wall St. Rank held Ingredion as of Q4 2025.

Based on Equitable Trust's 13F filing for Q4 2025, filed 2 Feb 2026.